The NSW Government is committed to developing a better understanding of the potential for cannabis and/or cannabis products to alleviate symptoms or potentially treat a range of debilitating or terminal illnesses.
To help further our understanding of cannabis and cannabis-derived substances for therapeutic purposes, the NSW Government has announced the establishment of the Centre for Medicinal Cannabis Research and Innovation.
The NSW Government is investing $9 million over the next five years on clinical trials of cannabis products. The trials will explore the use of cannabis and/or cannabis products in providing relief for patients suffering from severe paediatric epilepsy, chemotherapy-induced nausea and vomiting, and for symptom relief for those with terminal illness.
The NSW Government has developed the Medicinal Cannabis Compassionate Use Scheme to extend compassion to adults with a terminal illness. This Scheme was formerly named the Terminal Illness Cannabis Scheme.
The scheme provides guidelines for NSW Police Force officers to help them determine the appropriate circumstances in which to use their discretion not to charge adults with terminal illness who use cannabis and/or cannabis products to alleviate their symptoms, as well as carers who assist them.
Guidance for medical practitioners has also been developed to assist when patients are seeking medical certification to access the Scheme.
See Medicinal Cannabis Compassionate Use Scheme for more information.